Bolt Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bolt Biotherapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 37% to $7,876,000. The net income raised on -$69,197,000 and profit margin reached -879%. Total operating expenses were $84,072,000.
Profit Margin
| 2018 | 0 | -11.58M | |
|---|---|---|---|
| 2019 | 215K | -30.00M | -13955.81% |
| 2020 | 231K | -72.27M | -31287.45% |
| 2021 | 1.26M | -104.39M | -8285.24% |
| 2022 | 5.72M | -85.87M | -1498.95% |
| 2023 | 7.87M | -69.19M | -878.58% |
BOLT Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 7.87M | 5.72M | 1.26M | 231K | 215K | 0 |
Cost of revenue | 1.88M | 4.89M | 3.67M | 40.35M | 26.00M | 0 |
Gross profit | 5.99M | 838K | -2.41M | -40.12M | -25.78M | 0 |
Operating exp. | ||||||
Research and development | 61.54M | 73.12M | 75.65M | 40.35M | 26.00M | 9.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 84.07M | 96.05M | 94.04M | 49.41M | 31.18M | 11.62M |
Operating income | -76.19M | -90.32M | -92.78M | -49.18M | -30.96M | -11.62M |
Other income (expenses), net | 6.99M | 2.22M | -5.80M | -11.54M | 482K | -153K |
Income before tax | -69.19M | -88.09M | -98.59M | -60.72M | -30.48M | -11.58M |
Income tax expense | 0 | -2.22M | 5.80M | 11.54M | -482K | 40K |
Net income | -69.19M | -85.87M | -104.39M | -72.27M | -30.00M | -11.58M |
Earnings per share | ||||||
Basic EPS | -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
Diluted EPS | -1.83 | -2.3 | -2.79 | -1.99 | -0.85 | -1.23 |
| Data source | Data source | Data source | Data source |